A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells

Winter-Vann, Ann M., Baron, Rudi A., Wong, Waihay, dela Cruz, June, York, John D., Gooden, David M., Bergo, Martin O., Young, Stephen G. +2 more·2005·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.0408107102

Cited by (197)

Items 101–197 of 197

  1. Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors
    Joel A. Bergman, Kalub Hahne, Christine A. Hrycyna, Richard A. Gibbs · 2011 · Bioorganic & Medicinal Chemistry Letters
  2. Antimetabolites and cancer: emerging data with a focus on antifolates
    Giorgio V. Scagliotti, Giovanni Selvaggi · 2006 · Expert Opinion on Therapeutic Patents
  3. Isoprenylcysteine Carboxyl Methyltransferase and Its Substrate Ras Are Critical Players Regulating TLR-Mediated Inflammatory Responses
    Woo Seok Yang, Han Gyung Kim, Eunji Kim, Sang Yun Han, Nur Aziz, Young‐Su Yi, Sung-Gyu Kim, Yunmi Lee, Byong Chul Yoo, Jeung‐Whan Han et al. · 2020 · Cells
  4. Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
    Carla M. Borini Etichetti, Evelyn Arel Zalazar, Nabila Cocordano, Javier E. Girardini · 2020 · Frontiers in Oncology
  5. Control of RhoA Methylation by Carboxylesterase I
    Ian Cushman, Stephanie M. Cushman, Philip M. Potter, Patrick J. Casey · 2013 · Journal of Biological Chemistry
  6. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells
    Yehua Gan, Ying H. Shen, Budi Utama, Jian Wang, Joseph Stapleton Coselli, Xing Li Wang · 2005 · Biochemical and Biophysical Research Communications
  7. Synthesis of desthio prenylcysteine analogs: Sulfur is important for biological activity
    Brian S. Henriksen, Jessica L. Anderson, Christine A. Hrycyna, Richard A. Gibbs · 2005 · Bioorganic & Medicinal Chemistry Letters
  8. Eisenporphyrin‐katalysierte C‐H‐Funktionalisierung von Indol mit Diazoacetonitril für die Synthese von Tryptaminen
    Katharina J. Hock, Anja Knorrscheidt, Renè Hommelsheim, Junming Ho, Martin J. Weissenborn, René M. Koenigs · 2018 · Angewandte Chemie
  9. Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer
    Hsiao-Ching Chuang, Po-Hsien Huang, Samuel Kiyota Kulp, Ching‐Shih Chen · 2017 · Pharmacological Research
  10. Past and Future Strategies to Inhibit Membrane Localization of the KRAS Oncogene
    Malak Haidar, Patrick Jacquemin · 2021 · International Journal of Molecular Sciences
  11. Recent Progress in Developing Small Molecule Inhibitors Designed to Interfere with Ras Membrane Association
    Fuyuhiko Tamanoi, Jie Lu · 2013 · The Enzymes
  12. Analysis of Biosynthetic Gene Clusters, Secretory, and Antimicrobial Peptides Reveals Environmental Suitability of Exiguobacterium profundum PHM11
    Alok Kumar Srivastava, Ruchi Srivastava, Akhilendra Pratap Bharati, Alok Kumar Singh, Anjney Sharma, Sudipta Das, Praveen Kumar Tiwari, Anchal Kumar Srivastava, Hillol Chakdar, Prem Lal Kashyap et al. · 2022 · Frontiers in Microbiology
  13. Mutational Analysis of the Integral Membrane Methyltransferase Isoprenylcysteine Carboxyl Methyltransferase (ICMT) Reveals Potential Substrate Binding Sites
    Melinda M. Diver, Stephen Barstow Long · 2014 · Journal of Biological Chemistry
  14. Targeting Ras with Macromolecules
    Dehua Pei, Kuangyu Chen, Hui Liao · 2017 · Cold Spring Harbor Perspectives in Medicine
  15. The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation
    Fan Xie, Pengcheng Li, Jianhua Gong, Jiahong Zhang, Jingping Ma · 2015 · Biochemical and Biophysical Research Communications
  16. The Emerging Role of p21 in Diabetes and Related Metabolic Disorders
    Omar Saleh ElMitwalli, Radwan Darwish, Lana Al-Jabery, Ahmed Taymour Algahiny, Sornali Roy, Alexandra E. Butler, Ammar Shaker Hamed Hasan · 2024 · International Journal of Molecular Sciences
  17. Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors
    Pingyuan Wang, Dharini van der Hoeven, Na Ye, Haiying Chen, Zhiqing Liu, Xiaoping Ma, Dina Montufar‐Solis, Kristen M. Rehl, Kwang‐Jin Cho, Sabita Thapa et al. · 2021 · European Journal of Medicinal Chemistry
  18. Drug targeting opportunities en route to Ras nanoclusters
    Karolina Pavic, Rohan Chippalkatti, Daniel Abankwa · 2022 · Advances in cancer research
  19. Solid-Phase Synthesis of Prenylcysteine Analogs
    James L. Donelson, Heather B. Hodges, Brian S. Henriksen, Christine A. Hrycyna, Richard A. Gibbs · 2009 · The Journal of Organic Chemistry
  20. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation
    Qiong Liu, Jun Chen, Bingbing Fu, Jie Dai, Ying Zhao, Lin Lai · 2018 · Biochemical and Biophysical Research Communications
  21. Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
    Virna Cepero, Jose Rafael Sierra, Silvia Giordano · 2010 · Current Pharmaceutical Design
  22. Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia
    Wen Tian Sun, Wei Xiang, Bee Ling Ng, Kartini Asari, Ralph Milford Bunte, Patrick J. Casey, Mei Wang, Charles T. H. Chuah · 2015 · Experimental Hematology
  23. Ras inhibition by zoledronic acid effectively sensitizes cervical cancer to chemotherapy
    Jiazhen Xu, Qin Pan, Wenhui Ju · 2019 · Anti-Cancer Drugs
  24. Total synthesis of the natural isoprenylcysteine carboxyl methyltransferase inhibitor spermatinamine
    José Luis García, Raquel Pereira, Ángel R. de Lera · 2009 · Tetrahedron Letters
  25. Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk
    Weifeng Wan, Wenfeng Xiao, Wen Pan, Ligang Chen, Zhiyong Liu, Jianguo Xu · 2022 · Cancer Chemotherapy and Pharmacology
  26. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis
    Jiangrong Huang, Xiaoyu Yang, Xiaochun Peng, Wei Huang · 2017 · Biochemical and Biophysical Research Communications
  27. Quantitative structure–activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase
    Jolene Leow, Rudi Baron, Patrick J. Casey, Mei‐Lin Go · 2006 · Bioorganic & Medicinal Chemistry Letters
  28. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation
    Yongbo Zhu, Qiyan Hu, Hui Li · 2019 · Biochemical and Biophysical Research Communications
  29. Evaluating the Epithelial-Mesenchymal Program in Human Breast Epithelial Cells Cultured in Soft Agar Using a Novel Macromolecule Extraction Protocol
    Hiu Yeung Lau, Jingyi Tang, Patrick J. Casey, Mei Wang · 2021 · Cancers
  30. Overcoming chemoresistance in glioblastoma by fluvastatin via prenylation-dependent inhibition of Ras signaling
    Cheng Long, Limei Yuan, Wei Wei, Jingwen Li · 2022 · Human & Experimental Toxicology
  31. 10 Genetic approaches to understanding the physiologic importance of the carboxyl methylation of isoprenylated proteins
    Stephen G. Young, Steven Gerard Clarke, Martin O Bergoc, Mark Phillips, Loren G. Fong · 2006 · The Enzymes
  32. Niclosamide: A career builder
    David Needham · 2024 · Journal of Controlled Release
  33. Folylpolyglutamate synthetase mRNA G-quadruplexes regulate its cell protrusion localization and enhance a cancer cell invasive phenotype upon folate repletion
    Michal Stark, May Levin, Igor Ulitsky, Yehuda G. Assaraf · 2023 · BMC Biology
  34. Quantitative Determination of Cellular Farnesyltransferase Activity: Towards Defining the Minimum Substrate Reactivity for Biologically Relevant Protein Farnesylation
    Susan Flynn, Danielle E. Lindgren, James L. Hougland · 2014 · ChemBioChem
  35. An In Vivo Inflammatory Loop Potentiates KRAS Blockade
    Kristina A. M. Arendt, Giannoula Ntaliarda, Vasileios Armenis, Danai Kati, Christin Henning, Georgia A. Giotopoulou, Mario A. A. Pepe, Laura Valentina Klotz, Anne‐Sophie Lamort, Rudolf Alexander Hatz et al. · 2022 · Biomedicines
  36. An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
    Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, Rehab Mustafa Badi, Hoda Atef Abdelsattar Ibrahim, Eslam B. Elkaeed, Wagdy Mohamed Eldehna · 2024 · Molecular Diversity
  37. Small change, big effect: Taking RAS by the tail through suppression of post-prenylation carboxylmethylation
    Hiu Yeung Lau, Mei Wang · 2017 · Small GTPases
  38. 9 Structure and function of isoprenylcysteine carboxylmethyltransferase (Icmt): A key enzyme in CaaX processing
    Jessica L. Anderson, Christine A. Hrycyna · 2006 · The Enzymes
  39. Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer
    Behshid Ghadrdoost Nakhchi, Ramoji Kosuru, Magdalena Chrzanowska‐Wodnicka · 2024 · International Journal of Molecular Sciences
  40. Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance
    Anxo Río-Vilariño, Laura del Puerto‐Nevado, Jesús García‐Foncillas, Arancha Cebrián · 2021 · Cancers
  41. Isoprenylcysteine carboxyl methyltransferase inhibitors: QSAR, docking and molecular dynamics studies
    Nilima R. Das, Tripti Sharma, Nainee Goyal, N. Singh, Andrey Andreevich Toropov, Alla P. Toropova, Patnala Ganga Raju Achary · 2023 · Journal of Molecular Structure
  42. Non-substrate based, small molecule inhibitors of the human isoprenylcysteine carboxyl methyltransferase
    Kyle Vincent Butler, Kelsey C. Bohn, Christine A. Hrycyna, Jian Jun Jin · 2016 · MedChemComm
  43. A high-performance liquid chromatography method for the quantification of cysmethynil, an inhibitor of isoprenylcysteine carboxylmethyl transferase, in mouse plasma
    Mei Wang, Yok Moi Khoo, Jin Zhou, Patrick J. Casey, How Sung Lee · 2009 · Journal of Chromatography B
  44. Recent Advances in the Synthesis of Nitrile Compounds Utilizing K 4 [Fe(CN) 6 ]: Mechanistic Studies and Applications
    Yan Zhang, Fachao Yan, Yue Zhang, Qing Liu, Hui Liu · 2025 · Chemistry - An Asian Journal
  45. Alterations in molecular chaperones and eIF2α during lung endothelial cell apoptosis
    Qing Lü, Matthew D. Jankowich, Julie Newton, Elizabeth O. Harrington, Sharon Rounds · 2010 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  46. KRAS mutations in colorectal cancer: impacts on tumor microenvironment and therapeutic implications
    Anita Emami, Pouya Mahdavi Sharif, Nima Rezaei · 2025 · Expert Opinion on Therapeutic Targets
  47. Targeting MDM2, RAS, and PCNA for cancer targeted therapy: pan-cancer approaches vs. cancer-specific strategies
    Wei Wang, Abigail Alley, Na Sun, Meheret Tadesse, Xinshi Wang, Ruiwen Zhang · 2025 · Frontiers in Pharmacology
  48. Identification of a novel nanomolar inhibitor of hIcmt via a carboxylate replacement approach
    Jaimeen D. Majmudar, Amanda Morrison-Logue, Jiao Song, Christine A. Hrycyna, Richard A. Gibbs · 2012 · MedChemComm
  49. Targeting Ras for Anticancer Drug Discovery
    Jen Jen Yeh, James P. Madigan, Paul M. Campbell, Patrick J. Roberts, Lanika DeGraffenreid, Channing J. Der · 2010 · Elsevier eBooks
  50. Prenylation-dependent Ras inhibition by pamidronate inhibits pediatric acute myeloid leukemia stem and differentiated cell growth and survival
    Chengbin Wang, Xiaohui Liu, Ru He, Junhua Li, Rui Pan · 2019 · Biochemical and Biophysical Research Communications
  51. Lipophilic modification of salirasib modulates the antiproliferative and antimigratory activity
    Ballari, María Sol, O. J. Porta, Exequiel, Zalazar, Evelyn Arel, Etichetti, Carla M. Borini, Padrón, José M., Girardini, Javier E., Labadie, Guillermo R. · 2023 · Bioorganic & Medicinal Chemistry
  52. Solid-phase synthesis of Biotin-S-Farnesyl-l-Cysteine, a surrogate substrate for isoprenylcysteine Carboxylmethyltransferase (ICMT)
    Graeme I. Stevenson, Sarah R. Yong, Gregory A. Fechner, Juliette E. Neve, Aaron M. Lock, Vicky M. Avery · 2013 · Bioorganic & Medicinal Chemistry Letters
  53. Inhibitors of Postprenylation CAAX Processing Enzymes
    2011 · The Enzymes
  54. Mechanisms of CaaX Protein Processing: Protein Prenylation by FTase and GGTase-I
    Melanie J. Blanden, Sudhat Ashok, James L. Hougland · 2020 · Elsevier eBooks
  55. The Ras Converting Enzyme (Rce1p)
    Walter K. Schmidt, Timothy M. Dore · 2011 · The Enzymes
  56. Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair
    Jingyi Tang, Patrick J. Casey, Mei Wang · 2021 · Life Science Alliance
  57. 3-Carbamoylmethyl-Indole-1-Carboxylic Acid Ethyl Ester
    Yordanka Mollova-Sapundzhieva, Plamen Angelov, Pavel Yanev · 2022 · Molbank
  58. Targeting RAS membrane association
    Mei Wang, Patrick J. Casey, Cristina Nuevo‐Tapioles, Mark R. Philips · 2024 · Elsevier eBooks
  59. Search for Inhibitors of Ras-Driven Cancers
    Adam B. Keeton, Gary Anthony Piazza · 2016 · Elsevier eBooks
  60. Inactivation of isoprenylcysteine carboxyl methyltransferase reduces proliferation of BRAF and NRAS mutated human melanoma cells
    Bjarni Thorisson · 2011 · Chalmers Publication Library (Chalmers University of Technology)
  61. Targeting the Ras-Ral effector pathway for cancer treatment
    Leanna R. Gentry · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  62. Isoprenylcysteine carboxylmethyltransferase-based therapy for Hutchinson–Gilford progeria syndrome
    Beatriz Marcos‐Ramiro, Ana Gil-Ordóñez, Nagore I. Marín‐Ramos, Francisco J. Ortega-Nogales, Moisés Balabasquer, Pilar Gonzalo, Loïc Rolas, Anna Barkaway, Sussan Nourshargh, Vicente Andrés et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Iron-Catalyzed C—H Insertions: Organometallic and Enzymatic Carbene Transfer Reactions
    Katharina J. Hock, Anja Knorrscheidt, Renè Hommelsheim, Junming Ho, Martin J. Weissenborn, René M. Koenigs · 2018 · ChemRxiv
  64. Icmt
    Yuri Karl Peterson, Ann M. Winter-Vann, Patrick J. Casey · 2005 · AfCS-Nature Molecule Pages
  65. Investigação das quinases Aurora A e Aurora B como potenciais alvos terapêuticos no câncer de pulmão induzido pelo oncogene KRAS
    Edmilson Ozorio dos Santos · 2013
  66. La ruta RAS-ERK como diana antitumoral
    Piero Crespo · 2009 · DIGITAL.CSIC (Spanish National Research Council (CSIC))
  67. ISOPRENOID ANALOGS AS CHEMICAL GENETIC TOOLS TO PROVIDE INSIGHTS INTO FARNESYL TRANSFERASE TARGET SELECTION AND CELLULAR ACTIVITY
    Jerry M. Troutman · 2006 · UKnowledge (University of Kentucky)
  68. Defining RCE1 and ICMT as Therapeutic Targets in K-RAS-induced Cancer
    Annika M. Wahlstrom · 2009 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  69. Cysmethynil, a Specific Small-Molecule Inhibitor of Isoprenylcysteine Carboxylmethyl Transferase (Icmt)
    Mei Wang · 2011 · The Enzymes
  70. Anti-Ras Strategies for Cancer Treatment
    James J. Fiordalisi, Channing J. Der, Adrienne D. Cox · 2006 · Springer eBooks
  71. Investigação das quinases Aurora A e Aurora B na tumorigenicidade mediada pelo oncogene KRAS
    Edmilson Ozorio dos Santos · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  72. Lipophilic Salirasib analogs with enhanced antiproliferative activity against human solid tumor cell lines
    Exequiel O. J. Porta, María Sol Ballari, José M. Padrón, Guillermo R. Labadié · 2021 · ChemRxiv
  73. Icmt (Isoprenylcysteine Carboxyl Methyltransferase)
    Kathryn M. Appleton, Ian Cushman, Yuri Karl Peterson · 2016 · Springer eBooks
  74. Icmt (Isoprenylcysteine Carboxyl Methyltransferase)
    Kathryn M. Appleton, Ian Cushman, Yuri Karl Peterson · 2017 · Springer eBooks
  75. Icmt (Isoprenylcysteine Carboxyl Methyltransferase)
    Kathryn M. Appleton, Ian Cushman, Yuri Karl Peterson · 2012 · Springer eBooks
  76. Avaliação de possíveis inibidores da biossíntese de produtos isoprenilados e estudo da biossíntese de prenilquinonas nos estágios intraerotricitários de Plasmodium falciparum.
    Ignasi Bofill Verdaguer · 2019
  77. Concurrent inhibition of ICMT and RAF/MEK suppresses RAC1 P29S -driven MAPKi resistance in BRAF V600E melanoma by regulating TAZ activity
    Xiaoyang Gu, Patrick J. Casey, Mei Wang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  78. ICMT supports BRAF V600E -driven tumor growth by membrane targeting of the CAAX protein INPP5E
    Xijie Yang, Xi Qiao, Sarah Schmidt, Ella Äng Eklund, Carolina Ebner-Walter, Emil G. Ivarsson, Michelle Ann Crespo, Nadieh Kersemakers, Jozefina J. Dzanan, Bjarni Thorisson et al. · 2026 · Proceedings of the National Academy of Sciences
  79. BindingDB Entry 50039805: S-Farnesyl-Thiopropionic Acid (FTPA) Triazoles as Potent Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase.
    BindingDB · 2013 · UC San Diego
  80. BindingDB Entry 50013756: Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors.
    BindingDB · 2022 · UC San Diego
  81. BindingDB Entry 50047691: Non-Substrate Based, Small Molecule Inhibitors of the Human Isoprenylcysteine Carboxyl Methyltransferase.
    BindingDB · 2017 · UC San Diego
  82. BindingDB Entry 50045098: Development of synthetic lethality anticancer therapeutics.
    BindingDB · 2016 · UC San Diego
  83. BindingDB Entry 50021556: Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target.
    BindingDB · 2009 · UC San Diego
  84. BindingDB Entry 50017349: Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway.
    BindingDB · 2023 · UC San Diego
  85. BindingDB Entry 50033883: Lipid and sulfur substituted prenylcysteine analogs as human Icmt inhibitors.
    BindingDB · 2012 · UC San Diego
  86. BindingDB Entry 50034481: Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization.
    BindingDB · 2012 · UC San Diego
  87. BindingDB Entry 50017959: Amide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferase.
    BindingDB · 2009 · UC San Diego
  88. BindingDB Entry 50037603: Synthesis of desthio prenylcysteine analogs: sulfur is important for biological activity.
    BindingDB · 2012 · UC San Diego
  89. BindingDB Entry 50043100: Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
    BindingDB · 2014 · UC San Diego
  90. BindingDB Entry 50042909: Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt).
    BindingDB · 2014 · UC San Diego
  91. BindingDB Entry 50042134: Ras inhibition via direct Ras binding--is there a path forward?
    BindingDB · 2013 · UC San Diego
  92. BindingDB Entry 50004134: Aplysamine 6, an alkaloidal inhibitor of Isoprenylcysteine carboxyl methyltransferase from the sponge Pseudoceratina sp.
    BindingDB · 2020 · UC San Diego
  93. BindingDB Entry 50008021: A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.
    BindingDB · 2021 · UC San Diego
  94. BindingDB Entry 50032360: Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase.
    BindingDB · 2011 · UC San Diego
  95. BindingDB Entry 50033599: Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
    BindingDB · 2012 · UC San Diego
  96. BindingDB Entry 50033282: Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors.
    BindingDB · 2011 · UC San Diego
  97. BindingDB Entry 50041522: Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.
    BindingDB · 2013 · UC San Diego